West Pharmaceutical Services, Inc.
WST
$352.50
$0.370.11%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 564.90M | 542.70M | 493.70M | 491.70M | 487.70M |
| Total Depreciation and Amortization | 181.40M | 176.60M | 171.40M | 165.10M | 162.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.00M | 19.20M | 9.90M | 15.40M | 7.30M |
| Change in Net Operating Assets | -105.10M | -23.20M | 79.80M | 21.60M | 19.40M |
| Cash from Operations | 662.20M | 715.30M | 754.80M | 693.80M | 676.70M |
| Capital Expenditure | -225.30M | -257.30M | -285.90M | -314.70M | -332.70M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00K | -700.00K |
| Cash from Investing | -225.30M | -257.30M | -285.90M | -314.60M | -333.40M |
| Total Debt Issued | 50.00M | -- | -- | 0.00 | 129.70M |
| Total Debt Repaid | -51.30M | -1.20M | -1.10M | -900.00K | -133.80M |
| Issuance of Common Stock | 24.90M | 21.30M | 18.20M | 16.70M | 18.70M |
| Repurchase of Common Stock | -457.10M | -300.90M | -136.80M | -191.20M | -243.50M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -62.40M | -61.80M | -61.20M | -60.70M | -60.10M |
| Other Financing Activities | -800.00K | -4.20M | -4.20M | -6.20M | -6.20M |
| Cash from Financing | -496.70M | -346.80M | -185.10M | -242.30M | -295.20M |
| Foreign Exchange rate Adjustments | -14.10M | 6.00M | 22.90M | 700.00K | 15.40M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.90M | 117.20M | 306.70M | 137.60M | 63.50M |